Get the Stockscreener App
7.575
1.75%
0.13
After Hours:
7.58
0.005
+0.07%
Pharming Group N V Adr stock is traded at $7.575, with a volume of 4,558.
It is up +1.75% in the last 24 hours and down -12.93% over the past month.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
See More
Previous Close:
$7.445
Open:
$7.55
24h Volume:
4,558
Relative Volume:
0.70
Market Cap:
$534.54M
Revenue:
$277.56M
Net Income/Loss:
$-13.33M
P/E Ratio:
-29.13
EPS:
-0.26
Net Cash Flow:
$-6.54M
1W Performance:
-1.37%
1M Performance:
-12.93%
6M Performance:
-18.64%
1Y Performance:
-35.26%
1-Day Range:
$7.55
$7.95
1-Week Range:
$7.31
$7.95
52-Week Range:
$6.65
$13.20
Pharming Group N V Adr Stock (PHAR) Company Profile
Compare PHAR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
7.575 | 534.54M | 277.56M | -13.33M | -6.54M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Pharming Group N V Adr Stock (PHAR) Latest News
Pharming Group to participate in November investor conference - GlobeNewswire Inc.
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com India
Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com
Earnings call: Pharming Group NV sees robust growth in Q3, CEO to step down - Investing.com
October 2024's Promising Penny Stocks to Watch - Yahoo Finance
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com India
Pharming Group stock hits 52-week low at $6.9 amid challenges - Investing.com
Shoals Technologies, Affirm Holdings, Apple And Other Big Stocks Moving Higher On Tuesday By Benzinga - Investing.com UK
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ... - Investing.com UK
J.M. Smucker Posts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks ... - Investing.com UK
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBa - Benzinga
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session By Benzinga - Investing.com UK
Magenta (MGTA) Down on Pipeline Update for Leukemia Drug - Yahoo Canada Shine On
Earnings call: Pharming Group reports strong Q1 growth, eyes global expansion By Investing.com - Investing.com UK
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains? - Yahoo Finance
Heineken® Celebrates Historic Irish Pubs With Virtual Museums Launch | GlobeNewswire by notified - NTB Kommunikasjon
PHAR Stock Quote Price and Forecast - CNN
PHARMING GROUP NV Trade Ideas — TRADEGATE:PHGN — TradingView - TradingView
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Nasdaq
How Investors Can Grab Better Returns for Retail and Wholesale Using the Zacks ESP Screener - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Pharming Group N V Adr Stock (PHAR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):